Metformin and cancer mortality

The author analyses recent publications supporting the ability of metformin to decrease the risk of cancer morbidity and mortality in patients with type 2diabetes mellitus. Pre-history of the problem (including the use of biguanides for metabolic rehabilitation of oncological patients), the role of...

Description complète

Enregistré dans:
Détails bibliographiques
Auteur principal: Lev Mikhaylovich Bershteyn
Format: article
Langue:EN
RU
Publié: Endocrinology Research Centre 2010
Sujets:
Accès en ligne:https://doaj.org/article/05da729af1a04fbb8decb7c01a66bd6a
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!